Is the use of PERIXa, the standardized protocol for perioperative factor Xa inhibitor discontinuation and resumption, associated with rates of major bleeding and thromboembolism among patients with atrial fibrillation (AF) undergoing procedures with minimal to low bleeding risk? The gene discussed is F10; the disease is atrial fibrillation.